After a period of significant volatility, Neogen Corporation (NEOG) is showing signs of a sustainable operational turnaround under new leadership, with its latest quarterly results beating expectations and prompting a rare guidance upgrade.
With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
Exclusive BBC analysis reveals nearly half of accredited zoos and aquariums in the UK and Ireland have sounded financial alarms since 2022, forcing tough choices between conservation missions and economic reality.
With prized Burmese teak off-limits due to sanctions and old-growth stocks dwindling, the luxury yacht industry is accelerating its search for viable—and sustainable—alternatives, from engineered woods to advanced synthetics.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Revvity shares have faced significant pressure, down over 13% in the past year. A deep dive into its valuation reveals a stark contradiction: while a cash flow model suggests the stock is undervalued, its price-to-earnings multiple tells a different story. We examine the numbers and what they mean for investors.
The arrest of BitRiver's founder on tax evasion charges coincides with an insolvency claim filed against the company, compounding pressures from sanctions, energy debts, and internal strife.
President Claudia Sheinbaum commits to humanitarian support and exploring fuel shipments to Cuba, directly challenging Trump administration efforts to isolate Havana. The move risks escalating tensions ahead of crucial U.S.-Mexico trade talks.
A male tourist in his 60s was killed in a violent encounter with a wild bull elephant, marking the third confirmed fatality linked to the same animal. Park authorities are now weighing intervention options as human-wildlife conflict escalates.
From under a dollar to over three, the price of a dozen eggs tells a story of inflation, disease, and changing agriculture. We break down the real cost by decade and explore what's driving your grocery bill higher.
A new report reveals a stark divergence in the U.S. housing market: while high rates cool mainstream activity, ultra-luxury sales above $10 million surged to a record $38.6 billion in 2025, driven by new wealth creation and a flight to tangible assets.
Raytheon, an RTX business, achieves a critical ballistic flight test for the U.S. Army's new interceptor while securing over $1.2 billion in new defense contracts. These wins solidify its role in next-generation air defense but come as the company's stock trades near record highs, prompting investor scrutiny over future growth.
A captive breeding program for the elusive Guthega skink in Victoria's high country yields a rare pregnancy, potentially boosting the known wild population from 11 to 13 individuals.
German Chancellor Friedrich Merz has called for urgent action to dismantle barriers and create a truly integrated European capital market, arguing it is essential for the bloc's economic competitiveness and to keep innovative firms from listing abroad.
Live and feeder cattle futures posted significant gains Monday, buoyed by a tighter-than-expected national herd and strong cash market fundamentals. The rally comes amid declining inventory numbers and sustained investor interest.
The Coast Guard has identified the seven individuals lost when the fishing vessel Lily Jean sank off the Massachusetts coast. As the community gathers to mourn, officials warn a complex investigation into the cause could take months.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
